• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将肽配体整合到三倍重复的刺突衣壳域中,以重新定向体内 AAV8 和 AAV9 的基因转导。

Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.

机构信息

Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

PLoS One. 2011;6(8):e23101. doi: 10.1371/journal.pone.0023101. Epub 2011 Aug 5.

DOI:10.1371/journal.pone.0023101
PMID:21850255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3151269/
Abstract

Efficiency and specificity of viral vectors are vital issues in gene therapy. Insertion of peptide ligands into the adeno-associated viral (AAV) capsid at receptor binding sites can re-target AAV2-derived vectors to alternative cell types. Also, the use of serotypes AAV8 and -9 is more efficient than AAV2 for gene transfer to certain tissues in vivo. Consequently, re-targeting of these serotypes by ligand insertion could be a promising approach but has not been explored so far. Here, we generated AAV8 and -9 vectors displaying peptides in the threefold spike capsid domain. These peptides had been selected from peptide libraries displayed on capsids of AAV serotype 2 to optimize systemic gene delivery to murine lung tissue and to breast cancer tissue in PymT transgenic mice (PymT). Such peptide insertions at position 590 of the AAV8 capsid and position 589 of the AAV9 capsid changed the transduction properties of both serotypes. However, both peptides inserted in AAV8 did not result in the same changes of tissue tropism as they did in AAV2. While the AAV2 peptides selected on murine lung tissue did not alter tropism of serotypes 8 and -9, insertion of the AAV2-derived peptide selected on breast cancer tissue augmented tumor gene delivery in both serotypes. Further, this peptide mediated a strong but unspecific in vivo gene transfer for AAV8 and abrogated transduction of various control tissues for AAV9. Our findings indicate that peptide insertion into defined sites of AAV8 and -9 capsids can change and improve their efficiency and specificity compared to their wild type variants and to AAV2, making these insertion sites attractive for the generation of novel targeted vectors in these serotypes.

摘要

病毒载体的效率和特异性是基因治疗中的关键问题。将肽配体插入到腺相关病毒(AAV)衣壳的受体结合部位,可以将源自 AAV2 的载体重新靶向到替代的细胞类型。此外,与 AAV2 相比,使用血清型 AAV8 和 -9 进行基因转移到体内某些组织更为有效。因此,通过插入配体来重新靶向这些血清型可能是一种很有前途的方法,但迄今为止尚未得到探索。在这里,我们生成了在三倍旋转衣壳域中显示肽的 AAV8 和 -9 载体。这些肽是从 AAV 血清型 2 的衣壳上展示的肽文库中选择出来的,用于优化系统基因传递到小鼠肺组织和 PymT 转基因小鼠(PymT)的乳腺癌组织。在 AAV8 衣壳的位置 590 和 AAV9 衣壳的位置 589 处插入这些肽改变了这两种血清型的转导特性。然而,插入 AAV8 中的两种肽并没有导致与 AAV2 相同的组织趋向性变化。虽然在小鼠肺组织上选择的 AAV2 肽没有改变血清型 8 和 -9 的趋向性,但插入来自乳腺癌组织的 AAV2 衍生肽增强了这两种血清型的肿瘤基因传递。此外,该肽介导了 AAV8 的强烈但非特异性的体内基因转移,并使 AAV9 的各种对照组织的转导失活。我们的研究结果表明,与野生型变体和 AAV2 相比,肽插入到 AAV8 和 -9 衣壳的特定部位可以改变和提高它们的效率和特异性,使这些插入部位成为在这些血清型中生成新型靶向载体的有吸引力的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/87a5002d0728/pone.0023101.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/e87ca9c70f03/pone.0023101.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/626ba3afc5fd/pone.0023101.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/4c55a75b49b0/pone.0023101.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/33361f5b286e/pone.0023101.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/6f9916063307/pone.0023101.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/87a5002d0728/pone.0023101.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/e87ca9c70f03/pone.0023101.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/626ba3afc5fd/pone.0023101.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/4c55a75b49b0/pone.0023101.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/33361f5b286e/pone.0023101.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/6f9916063307/pone.0023101.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1882/3151269/87a5002d0728/pone.0023101.g006.jpg

相似文献

1
Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.将肽配体整合到三倍重复的刺突衣壳域中,以重新定向体内 AAV8 和 AAV9 的基因转导。
PLoS One. 2011;6(8):e23101. doi: 10.1371/journal.pone.0023101. Epub 2011 Aug 5.
2
Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.多倍体腺相关病毒载体在转导增强和中和抗体逃逸中的应用。
J Control Release. 2017 Sep 28;262:348-356. doi: 10.1016/j.jconrel.2017.08.005. Epub 2017 Aug 5.
3
Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.嵌合衣壳蛋白影响单倍体腺相关病毒载体的转导效率。
Viruses. 2019 Dec 9;11(12):1138. doi: 10.3390/v11121138.
4
Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.硫酸乙酰肝素结合促进玻璃体内递送的腺相关病毒载体在视网膜的积累以增强转导,但对嗜性影响较弱。
J Virol. 2016 Oct 14;90(21):9878-9888. doi: 10.1128/JVI.01568-16. Print 2016 Nov 1.
5
Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.选择的肽配体对重组腺相关病毒血清型 2 介导的基因转导的衣壳修饰的影响。
J Gen Virol. 2012 Oct;93(Pt 10):2131-2141. doi: 10.1099/vir.0.044735-0. Epub 2012 Jul 4.
6
Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical.腺相关病毒血清型 2(AAV2)和 AAV8 衣壳抗原在体内的呈递动力学是相同的。
Hum Gene Ther. 2013 May;24(5):545-53. doi: 10.1089/hum.2013.065. Epub 2013 May 2.
7
Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.与AAV8衣壳血清型的腺相关病毒载体相比,AAV-1或-2血清型在向新生小鼠脑广泛递送基因方面效率更高。 (注:原文表述有误,实际应该是AAV8比AAV-1或-2更高效,译文已纠正)
Neuroscience. 2006;138(2):501-10. doi: 10.1016/j.neuroscience.2005.11.057. Epub 2006 Jan 18.
8
Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8.深入了解工程化腺相关病毒2型衣壳变体-7m8增强视网膜转导的机制。
Biotechnol Bioeng. 2016 Dec;113(12):2712-2724. doi: 10.1002/bit.26031. Epub 2016 Jun 30.
9
The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.腺相关病毒 8 型的三重突起参与细胞表面靶向以及附着后处理。
J Virol. 2012 Sep;86(17):9396-408. doi: 10.1128/JVI.00209-12. Epub 2012 Jun 20.
10
Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.腺相关病毒(AAV)衣壳结构域交换与肝脏转导效率关系的表征
Mol Ther. 2007 Nov;15(11):1955-62. doi: 10.1038/sj.mt.6300293. Epub 2007 Aug 28.

引用本文的文献

1
Identification of AAV variants with improved transduction of human vascular endothelial cells by screening AAV capsid libraries in non-human primates.通过在非人类灵长类动物中筛选腺相关病毒(AAV)衣壳文库来鉴定对人血管内皮细胞转导能力有所改善的AAV变体。
Gene Ther. 2025 Aug 22. doi: 10.1038/s41434-025-00563-4.
2
AAV Capsid Modification and Its Influence on Viral Protein Stoichiometry and Packaging Fitness: Current Understandings and Future Direction.腺相关病毒衣壳修饰及其对病毒蛋白化学计量和包装适应性的影响:当前认识与未来方向
Mol Biotechnol. 2025 Jan 29. doi: 10.1007/s12033-025-01381-0.
3
New AAV9 engineered variants with enhanced neurotropism and reduced liver off-targeting in mice and marmosets.

本文引用的文献

1
Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles.改组腺相关病毒基因组的工程设计与筛选:一种生产靶向生物纳米颗粒的新策略。
Mol Ther. 2008 Jul;16(7):1252-1260. doi: 10.1038/mt.2008.100. Epub 2016 Dec 8.
2
Terminal N-linked galactose is the primary receptor for adeno-associated virus 9.末端 N-连接半乳糖是腺相关病毒 9 的主要受体。
J Biol Chem. 2011 Apr 15;286(15):13532-40. doi: 10.1074/jbc.M110.210922. Epub 2011 Feb 17.
3
Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library.
在小鼠和狨猴中具有增强的嗜神经性和降低肝脏脱靶效应的新型工程化AAV9变体。
iScience. 2024 Apr 18;27(5):109777. doi: 10.1016/j.isci.2024.109777. eCollection 2024 May 17.
4
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases.用于神经退行性疾病的重组腺相关病毒载体的研究进展
Biomedicines. 2023 Oct 8;11(10):2725. doi: 10.3390/biomedicines11102725.
5
Structure-guided AAV capsid evolution strategies for enhanced CNS gene delivery.基于结构的 AAV 衣壳进化策略用于增强中枢神经系统基因传递。
Nat Protoc. 2023 Nov;18(11):3413-3459. doi: 10.1038/s41596-023-00875-y. Epub 2023 Sep 21.
6
AAV vectors: The Rubik's cube of human gene therapy.AAV 载体:人类基因治疗的魔方。
Mol Ther. 2022 Dec 7;30(12):3515-3541. doi: 10.1016/j.ymthe.2022.09.015. Epub 2022 Oct 5.
7
Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid.通过对腺相关病毒衣壳上未充分研究的位点进行定向进化,在静脉注射后靶向肺上皮细胞。
Mol Ther Methods Clin Dev. 2022 Aug 1;26:331-342. doi: 10.1016/j.omtm.2022.07.010. eCollection 2022 Sep 8.
8
Multimodal imaging of capsid and cargo reveals differential brain targeting and liver detargeting of systemically-administered AAVs.多模态成像衣壳和货物揭示了系统给药的 AAV 在大脑和肝脏的靶向差异。
Biomaterials. 2022 Sep;288:121701. doi: 10.1016/j.biomaterials.2022.121701. Epub 2022 Aug 6.
9
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions.癌症免疫治疗中胞内抗体的治疗潜力:现状与未来方向
Antibodies (Basel). 2022 Jul 18;11(3):49. doi: 10.3390/antib11030049.
10
AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset.在小鼠和狨猴静脉注射后具有全脑转基因表达且肝脏靶向性降低的腺相关病毒衣壳变体。
Nat Neurosci. 2022 Jan;25(1):106-115. doi: 10.1038/s41593-021-00969-4. Epub 2021 Dec 9.
通过体内筛选随机病毒展示肽文库选择心脏靶向腺相关病毒载体。
Gene Ther. 2010 Aug;17(8):980-90. doi: 10.1038/gt.2010.44. Epub 2010 Apr 15.
4
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.健康人群血清 IgG 及中和因子针对腺相关病毒(AAV)血清型 1、2、5、6、8 和 9 的流行率:对使用 AAV 载体的基因治疗的影响。
Hum Gene Ther. 2010 Jun;21(6):704-12. doi: 10.1089/hum.2009.182.
5
Adeno-associated viral vectors and their redirection to cell-type specific receptors.腺相关病毒载体及其向细胞类型特异性受体的重定向。
Adv Genet. 2009;67:29-60. doi: 10.1016/S0065-2660(09)67002-4.
6
A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery.一种在 AAV2 上展示的靶向肌肉的肽可改善全身给药时的肌肉趋向性。
Gene Ther. 2009 Aug;16(8):953-62. doi: 10.1038/gt.2009.59. Epub 2009 May 28.
7
Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders.腺相关病毒血清型和基因组结构对雌雄小鼠肝脏转导及生物分布的影响。
Hum Gene Ther. 2009 Aug;20(8):908-17. doi: 10.1089/hum.2009.031.
8
Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.静脉注射自我互补的腺相关病毒9型可使转基因传递至成年运动神经元。
Mol Ther. 2009 Jul;17(7):1187-96. doi: 10.1038/mt.2009.71. Epub 2009 Apr 14.
9
Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries.通过随机病毒展示肽库的体内生物淘选成功扩展但未完全限制腺相关病毒的嗜性。
PLoS One. 2009;4(4):e5122. doi: 10.1371/journal.pone.0005122. Epub 2009 Apr 9.
10
AAV9: a potential blood-brain barrier buster.腺相关病毒9型:一种潜在的血脑屏障突破者。
Mol Ther. 2009 Mar;17(3):403-5. doi: 10.1038/mt.2009.15.